A Phase 3, Multicenter, Placeno-Controlled, Randomized, Observer-Blinded Trial to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, and Lot Consistency of a 6-Valent Ospa-based Lyme Disease Vaccine in Healthy Participants >5 Year